Skip to main content

Murphy Andrew J's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed Nov 17, 2021

Accession no.
0001708138-21-000086
Filed
Nov 17, 2021
Trade date
Aug 16-Nov 16, 2021
Filing delay
93 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 20 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.64M. It was filed 93 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Murphy Andrew JCIK 0001796226Officer (EVP Research)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 16, 2021Common StockGGiftDisposed−1,645$0.00$055,705Direct
Nov 15, 2021Common StockMOption exerciseAcquired+16,579$52.03+$862,605.3772,284Direct
Nov 15, 2021Common StockFTax withholdingDisposed−9,412$641.50−$6,037,79862,872Direct
Nov 16, 2021Common StockSSaleDisposed−465$642.76F2−$298,883.462,407Direct
Nov 16, 2021Common StockSSaleDisposed−924$643.42F3−$594,520.0861,483Direct
Nov 16, 2021Common StockSSaleDisposed−1,106$644.71F4−$713,049.2660,377Direct
Nov 16, 2021Common StockSSaleDisposed−1,640$645.41F5−$1,058,472.458,737Direct
Nov 16, 2021Common StockSSaleDisposed−557$646.52F6−$360,111.6458,180Direct
Nov 16, 2021Common StockSSaleDisposed−844$647.39F7−$546,397.1657,336Direct
Nov 16, 2021Common StockSSaleDisposed−86$648.20F8−$55,745.257,250Direct
Nov 16, 2021Common StockSSaleDisposed−5$649.26−$3,246.357,245Direct
Nov 16, 2021Common StockSSaleDisposed−296$651.42F9−$192,820.3256,949Direct
Nov 16, 2021Common StockSSaleDisposed−133$652.24F10−$86,747.9256,816Direct
Nov 16, 2021Common StockSSaleDisposed−454$653.31F11−$296,602.7456,362Direct
Nov 16, 2021Common StockSSaleDisposed−198$654.34F12−$129,559.3256,164Direct
Nov 16, 2021Common StockSSaleDisposed−92$655.30F13−$60,287.656,072Direct
Nov 16, 2021Common StockSSaleDisposed−74$657.46−$48,652.0455,998Direct
Nov 16, 2021Common StockSSaleDisposed−71$658.56−$46,757.7655,927Direct
Nov 16, 2021Common StockSSaleDisposed−155$659.15F14−$102,168.2555,772Direct
Nov 16, 2021Common StockSSaleDisposed−67$660.32−$44,241.4455,705Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 15, 2021Common StockMOption exerciseDisposed−16,579$0.00$016,500Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 465 shares of Company stock on November 16, 2021 at prices ranging from $642.35 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 924 shares of Company stock on November 16, 2021 at prices ranging from $643.07 to $643.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 1,106 shares of Company stock on November 16, 2021 at prices ranging from $644.24 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 1,640 shares of Company stock on November 16, 2021 at prices ranging from $645.01 to $645.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 557 shares of Company stock on November 16, 2021 at prices ranging from $646.12 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 844 shares of Company stock on November 16, 2021 at prices ranging from $647.09 to $647.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 86 shares of Company stock on November 16, 2021 at prices ranging from $648.15 to $648.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 296 shares of Company stock on November 16, 2021 at prices ranging from $651.00 to $651.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 133 shares of Company stock on November 16, 2021 at prices ranging from $652.22 to $652.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 454 shares of Company stock on November 16, 2021 at prices ranging from $653.04 to $653.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Represents volume-weighted average price of sales of 198 shares of Company stock on November 16, 2021 at prices ranging from $654.07 to $654.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

Represents volume-weighted average price of sales of 92 shares of Company stock on November 16, 2021 at prices ranging from $655.20 to $655.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

F14

Represents volume-weighted average price of sales of 155 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)